Literature DB >> 14520623

Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism.

Aiji Yajima1, Yoshihide Ogawa, Hideaki E Takahashi, Yoshihiro Tominaga, Tsunamasa Inou, Osamu Otsubo.   

Abstract

BACKGROUND: Successful parathyroidectomy for secondary hyperparathyroidism alleviates bone pain and is followed by the development of hypophosphatemia and hypocalcemia, as well as an increase in bone mineral density. An increase in osteoblast surface (Ob.S/BS) is not observed several months after surgery. In this study, we investigated early bone changes at 1 week after parathyroidectomy and the mechanism underlying an increase in bone mineral density.
METHODS: Fourteen patients with severe secondary hyperparathyroidism underwent iliac bone biopsy before and 1 week after parathyroidectomy. Changes in histomorphometric parameters, including osteoclast surface (Oc.S/BS), eroded surface (ES/BS), erosion depth (E.De), fibrosis volume (Fb.V/TV), Ob.S/BS, osteoid volume (OV/BV), osteoid surface (OS/BS), and osteoid thickness (O.Th), were investigated. Changes in texture of mineralized bone and osteoid seams were also investigated.
RESULTS: Oc.S/BS (P < 0.001), ES/BS (P < 0.01), and E.De (P < 0.001) decreased, but Fb.V/TV did not change at 1 week postoperatively. In particular, osteoclasts disappeared in almost all patients. Ob.S/BS (P < 0.001) increased, and cuboidal osteoblasts were proliferating on the trabecular surface where osteoclasts had existed before parathyroidectomy. As a result, newly developed osteoblasts coexisted with fibrous tissue after surgery. OV/BV (P < 0.005), OS/BS (P < 0.005), and O.Th (P < 0.005) increased, with lamellar osteoid volume showing a particular increase. Bone mineralization continued despite the low postoperative serum parathyroid hormone level.
CONCLUSION: A rapid decrease in serum parathyroid hormone level after parathyroidectomy appears to suppress bone resorption, as well as cause a transient marked increase in bone formation and an increase in normal lamellar osteoid seams.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520623     DOI: 10.1016/s0272-6386(03)00909-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

Review 1.  Hyperparathyroidism of Renal Disease.

Authors:  Noah K Yuen; Shubha Ananthakrishnan; Michael J Campbell
Journal:  Perm J       Date:  2016-07-22

Review 2.  Old and New Drugs for the Management of Bone Disorders in CKD.

Authors:  Hirotaka Komaba; Markus Ketteler; John Cunningham; Masafumi Fukagawa
Journal:  Calcif Tissue Int       Date:  2021-01-02       Impact factor: 4.333

3.  Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Authors:  Sharon M Moe; Safa Abdalla; Glenn M Chertow; Patrick S Parfrey; Geoffrey A Block; Ricardo Correa-Rotter; Jürgen Floege; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; David C Wheeler; Bastian Dehmel; William G Goodman; Tilman B Drüeke
Journal:  J Am Soc Nephrol       Date:  2014-12-11       Impact factor: 10.121

4.  The case for routine parathyroid hormone monitoring.

Authors:  Stuart M Sprague; Sharon M Moe
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

5.  Perioperative hyperkalemia in hemodialysis patients undergoing parathyroidectomy for renal hyperparathyroidism.

Authors:  Guang Yang; Jing Wang; Jie Sun; Xiaoming Zha; Ningning Wang; Changying Xing
Journal:  Intern Emerg Med       Date:  2019-01-16       Impact factor: 3.397

6.  Prolonged hospital stay after parathyroidectomy for secondary hyperparathyroidism.

Authors:  Shih-Ping Cheng; Chien-Liang Liu; Han-Hsiang Chen; Jie-Jen Lee; Tsang-Pai Liu; Tsen-Long Yang
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

7.  Patient-specific bone modelling and remodelling simulation of hypoparathyroidism based on human iliac crest biopsies.

Authors:  Patrik Christen; Keita Ito; Ralph Müller; Mishaela R Rubin; David W Dempster; John P Bilezikian; Bert van Rietbergen
Journal:  J Biomech       Date:  2012-08-09       Impact factor: 2.712

Review 8.  Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

9.  Natural History of Bone Disease following Kidney Transplantation.

Authors:  Hanne Skou Jørgensen; Geert Behets; Bert Bammens; Kathleen Claes; Bjorn Meijers; Maarten Naesens; Ben Sprangers; Dirk R J Kuypers; Etienne Cavalier; Patrick D'Haese; Pieter Evenepoel
Journal:  J Am Soc Nephrol       Date:  2022-01-19       Impact factor: 10.121

10.  Skeletal and mineral metabolic effects of risedronate in a rat model of high-turnover renal osteodystrophy.

Authors:  Hiroaki Ishida; Hirotaka Komaba; Naoto Hamano; Hideyuki Yamato; Kaichiro Sawada; Takehiko Wada; Michio Nakamura; Masafumi Fukagawa
Journal:  J Bone Miner Metab       Date:  2020-03-05       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.